Lakeside Advisors, Inc. Abb Vie Inc. Transaction History

Lakeside Advisors, Inc.

$156 Million
Q3 2024

A detailed history of Lakeside Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Lakeside Advisors, Inc. holds 17,176 shares of ABBV stock, worth $3.04 Million. This represents 2.17% of its overall portfolio holdings.

Number of Shares

17,176

Previous 17,601 2.41%

Holding current value

$3.04 Million

Previous $3.02 Million 12.36%

% of portfolio

2.17%

Previous 2.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$163.84 - $199.33 $69,632 - $84,715	-425 Reduced 2.41%	17,176 $3.39 Million
Q2 2024 Jul 29, 2024	SELL	$154.79 - $180.76 $61,916 - $72,304	-400 Reduced 2.22%	17,601 $3.02 Million
Q1 2024 Apr 29, 2024	BUY	$159.82 - $182.1 $5,593 - $6,373	35 Added 0.19%	18,001 $3.28 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $35,088 - $39,517	-255 Reduced 1.4%	17,966 $2.78 Million
Q3 2023 Oct 19, 2023	SELL	$133.59 - $154.65 $53,436 - $61,860	-400 Reduced 2.15%	18,221 $2.72 Million
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $13,251 - $16,490	-100 Reduced 0.53%	18,621 $2.51 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $7,230 - $8,327	-50 Reduced 0.27%	18,721 $2.98 Million
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $48,408 - $58,054	-350 Reduced 1.83%	18,771 $3.04 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $26,842 - $30,786	-200 Reduced 1.04%	19,121 $2.57 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $27,524 - $34,992	-200 Reduced 1.02%	19,321 $2.96 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $26,395 - $32,750	-200 Reduced 1.01%	19,521 $3.17 Million
Q4 2021 Mar 08, 2022	BUY	$107.43 - $135.93 $2.12 Million - $2.68 Million	19,721 New	19,721 $2.67 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lakeside Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lakeside Advisors, Inc. with notifications on news.

Account

Lakeside Advisors, Inc. Abb Vie Inc. Transaction History